Abstract
Much of the conceptual framework regarding how to study receptor function evolved from pharmacological investigation of drug action. Consequently, the historical account of the development of receptor theory in this chapter, as well as the outline of how to characterize receptors in intact tissues in chapter 2, will emphasize early investigations of drug action rather than (for example) physiological studies of hormone action. However, the reader must keep in mind that drug can be defined as any agent that affects living processes. Drugs presumably bind to receptors designed for interaction with endogenous hormones and neurotransmitters or other regulatory agents. By way of definition, agonist drugs are analogous to endogenous hormones and neurotransmitters in the sense that they elicit a biological effect, although the effect elicited may be stimulatory or inhibitory. In contrast, antagonist drugs are defined as agents that block receptor-mediated effects elicited by hormones, neurotransmitters, or agonist drugs by competing for receptor occupancy. Most often, antagonists do not appear to have an endogenous counterpart in the strict sense of a competitive inhibitor of receptor occupancy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albert, A. (1979) Chemotherapy: History and principles. In Selective Toxicity (6th ed.), Chapman and Hall (eds.). New York: John Wiley and Sons, pp. 182–199. (This section of chapter 6 summarized P. Erhlich’s fundamental contributions to chemotherapy and general “receptor” principles.)
Ariens, E.J. (1954) Affinity and intrinsic activity in the theory of competitive inhibition. Part I. Problems and theory. Arch. Int. Pharmacodyn. 99:32–49.
Ariens, E.J. (1960) Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn. 127:459–478.
Ariens, E.J. and deGroot, W.M. (1954) Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium-derivatives and succinyl-choline-esters. Arch. Int. Pharmacodyn. 99:193–205.
Barger, G. and Dale, H.H. (1910) Chemical structure and sympathomimetic action of amines. J. Physiol. 41:19–59.
Bernard, C. (1856) Physiological analysis of the properties of the muscular and nervous system by means of curare. Comptes Rendus Acad, de Sci. 43:825–829.
Translated and reprinted inReadings in Pharmacology, L. Shuster (ed.). Boston: Little, Brown and Company, pp. 73–81.
Black, J.W. and Leff, P. (1983) Operational models of pharmacological agonism. Proc. Royal Soc. London B. 220:141–162.
Black, J.W., Leff, P. and Shankley, N.P., with an appendix by J. Wood (1985) An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharm. 84:561–571.
Black, J.W. and Shankley, N.P. (1990) Interpretation of agonist affinity estimations: The question of distributed receptor states. Proc. Royal Soc. London B. 240: 503–518.
Changeux, J.-P. and Podleski, T.R. (1968) On the excitability and cooperativity of the electroplax membrane. Proc. Natl. Acad. Sci. USA 59:944–950.
Clark, A.J. (1926) The reaction between acetyl choline and muscle cells. J. Physiol. 61:530–546.
Clark, A.J. (1926) The antagonism of acetyl choline by atropine. J. Physiol. 61: 547–556.
Clark, A.J. (1927) The reaction between acetyl choline and muscle cells. Part II. J. Physiol. 64:123–143.
Clark, A.J. (1937) General Pharmacology. Berlin: Verlag von Julius Springer, pp. 61–98, 176–206 and 215–217.
Clark, A.J. and Raventos, J. (1937) The antagonism of acetylcholine and of quaternary ammonium salts. Quant. J. Exp. Physiol. 26:275–392.
Colquhoun, D. (1973) The relation between classical and cooperative models for drug action. In Drug Receptors, H.P. Rang (ed.). Baltimore: University Park, pp. 149–182.
Dale, H.H. (1914) The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharm. Exp. Ther. 6:174–190.
Erhlich, P. (1913) Chemotherapeutics: Scientific principles, methods and results. Lancet 2:445–451.
Furchgott, R.F. (1955) The pharmacology of vascular smooth muscle. Pharm. Rev. 7:183–235.
Furchgott, R.F. (1964) Receptor mechanisms. Ann. Rev. Pharmacology 4:21–50.
Furchgott, R.F. and Bhadrakom, S. (1953) Reactions of strips of rabbit aorta to epinephrine, isoproterenol, sodium nitrite and other drugs. J. Pharm. Exp. Ther. 108:129–143.
Gaddum, J.H. (1926) The action of adrenalin and ergotamine on the uterus of the rabbit. J. Physiol. 61:141–150.
Gaddum, J.H. (1937) The quantitative effects of antagonistic drugs. J. Physiol. 89: 7P-9P.
Gaddum, J.H. (1957) Theories of drug antagonism. Pharm. Rev. 9:211–217.
Goldstein, A., Aronow, L. and Kalman, S.M. (1974) Principles of Drug Action: The Basis of Pharmacology (2nd ed.). New York: John Wiley and Sons, pp. 82–111.
Karlin, A. (1967) On the application of a “plausible model” of allosteric proteins to the receptor of acetylcholine. J. Theoret. Biol. 16:306–320.
Langley, J.N. (1878) On the physiology of the salivary secretion. Part II. On the mutual antagonism of atropin and pilocarpin, having especial reference to their relations in the submaxillary gland of the cat. J. Physiol. 1:339–369.
Langley, J.N. (1909) On the contraction of muscle, chiefly in relation to the presence of “receptive” substances. Part IV. The effect of curare and of some other substances on the nicotine response of the sartorius and gastrocnemius muscles of the frog. J. Physiol. 39:235–295.
Lohse, M.J., Benovic, J.L., Caron, M.G. and Lefkowitz, R.J. (1990) Multiple pathways of rapid β2-adrenergic receptor desensitization: Delineation with specific inhibitors. J. Biol. Chem. 265(6):3202–3211, especially appendix pp. 3210–3211.
Monod, J., Wyman, J. and Changeux, J.-P. (1965) On the nature of allosteric transitions: A plausible model. J. Mol. Biol. 12:88–118.
Nickerson, M. (1956) Receptor occupancy and tissue response. Nature 78:697–698.
Paton, W.D.M. (1961) A theory of drug action based on the rate of drug-receptor combination. Proc. Royal Soc. London B. 154:21–69.
Stephenson, R.P. (1956) A modification of receptor theory. Br. J. Pharm. 11: 379–393.
Thron, C.D. (1973) On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol. 9:1–9.
Thron, C.D. and Waud, D.R. (1968) The rate of action of atropine. J. Pharm. Exp. Ther. 160:91–105.
Van Rossum, J.M. and Ariens, E.J. (1962) Receptor reserve and threshold phenomena. II. Theories on drug-action and a quantitative approach to spare receptors and threshold values. Arch. Int. Pharmacodyn. 136:385–413.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1996 kluwer Academic Publishers
About this chapter
Cite this chapter
Limbird, L.E. (1996). Historical Perspective. In: Cell Surface Receptors: A Short Course on Theory and Methods. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1255-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1255-0_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8535-9
Online ISBN: 978-1-4613-1255-0
eBook Packages: Springer Book Archive